News | July 16, 2022
Indian pharmaceutical companies to grow by 6-7% in FY2023: ICRA
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
ICRA expects the OPM of the sample set to moderate to 20.2% in FY2023 from 21.5% in FY2022.
To strengthen the integrated human-centric preventive health screening ‘Phygital’ ecosystem in India
Mittal will be driving expansion of the provider network across India
Advancing to IND-enabling studies with multiple drug candidates
Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S.
MedTel aims to raise series A for rapid business expansion, product improvement & conducting relevant clinical validation studies.
Athos will perform multi-omic molecular and genetic analyses using biopsies from archived and de-identified Lahey IBD patient samples
Proportion of the eligible population yet to receive a COVID-19 vaccine is comparatively small
_256_384.png)
Researchers from Bar-Ilan University find that even in old age, feeling young can lower the risks of developing physical disability and morbidity
Domestic devices are usually preferred over imported medical devices in the national or regional procurement.
Subscribe To Our Newsletter & Stay Updated
